Search clinical trials for: Long-term study in Chronic Kidney Disease

Total 485350 results

Karolinska Institutet

Active, not recruiting

Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

COVID-19

Sweden
FibroGen
AstraZeneca

Completed

Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants (ASPEN)

Anemia Associated With End Stage Renal Disease

United States
Acibadem University

Completed

Comparison of the Effectiveness of Virtual Reality and Video Assisted Exercises in Pediatric Chronic Kidney Disease.

Physical Activity | Exercise Addiction | Pediatric Kidney Disease

Turkey
PT. Daewoong Infion
Equilab International

Completed

The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients

Chronic Kidney Disease (CKD)

Indonesia
Akebia Therapeutics

Completed

20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Anemia | Chronic Kidney Disease

United States
Akebia Therapeutics

Completed

Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Anemia | Dialysis-Dependent Chronic Kidney Disease

United States, Italy, Korea, Republic of, Portugal, Russian Federation, Ukraine, Poland, Argentina, Brazil, Germany, Mexico
PT. Daewoong Infion
Equilab International

Completed

The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®

Chronic Kidney Disease (CKD)

Indonesia
Janssen-Cilag International NV

Terminated

A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment

Kidney Failure, Chronic

Germany
OHSU Knight Cancer Institute
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

Chronic Myeloproliferative Disorders | Fanconi Anemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Akebia Therapeutics

Completed

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Anemia | End Stage Renal Disease

United States
Akebia Therapeutics

Completed

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Anemia | Kidney Disease

United States
Akebia Therapeutics

Completed

Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Anemia | Kidney Disease

United States
Akebia Therapeutics

Completed

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Anemia | Dialysis-Dependent Chronic Kidney Disease

United States, Italy, Canada, Korea, Republic of, United Kingdom, Australia, Germany, Israel, France, Portugal, Bulgaria, Russian Federation, Ukraine, Poland, Brazil, Argentina, Mexico, Serbia
Akebia Therapeutics

Completed

Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4

Chronic Kidney Disease

United States
Akebia Therapeutics

Completed

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

Anemia | Non-Dialysis-Dependent Chronic Kidney Disease

United States, Italy, Spain, Czechia, Korea, Republic of, Malaysia, Australia, New Zealand, United Kingdom, Germany, Turkey, Ukraine, France, Hungary, Austria, Israel, Bulgaria, Russian Federation, Romania, Slovakia, South Africa, Canad... and more
Akebia Therapeutics

Completed

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Anemia | Non-Dialysis-Dependent Chronic Kidney Disease

United States, Italy, Korea, Republic of, Australia, New Zealand, South Africa, United Kingdom, Spain, Ukraine, Hungary, Israel, Bulgaria, Russian Federation, Mexico, Poland, Brazil, Argentina, Malaysia, Puerto Rico, France
University of Washington

Completed

A Guide to Conservative Care

End Stage Renal Disease | Patient Engagement | Dialysis | Decision Aid | End-of-life Care

United States
Vascudyne, Inc.

Completed

Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)

End Stage Renal Disease

Paraguay
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease

Chronic Kidney Disease

China
Astellas Pharma Inc

Completed

A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Secondary Hyperparathyroidism

Japan
University of North Carolina, Chapel Hill
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis

Chronic Kidney Disease Requiring Chronic Dialysis

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Food Effect Study of DDO-3055 Tablets in Healthy Subjects

Anemia in Chronic Kidney Disease

China
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)

Chronic Kidney Disease

United States, France, Italy, Ukraine, Argentina, Mexico, Poland, Canada, Brazil, Russian Federation, Czechia, Puerto Rico
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

Chronic Kidney Disease

United States, Poland, Ukraine, Spain, Argentina, Mexico, Canada, Brazil, Russian Federation, Puerto Rico, Germany, Czechia
Bristol-Myers Squibb

Withdrawn

Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico

Multiple Indications Cancer

Mexico
Boryung Pharmaceutical Co., Ltd

Completed

A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

Chronic Kidney Disease

Korea, Republic of
University of Calgary

Completed

Evaluation of Fructose Ingestion and the Renin Angiotensin System in Humans

Chronic Kidney Disease

Canada
Shire

Completed

Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP) (PEDAL)

Retinopathy of Prematurity (ROP)

United States, Italy, Netherlands, Poland, Sweden, United Kingdom
University of Washington
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation (CLEAR-PLUS)

Chronic Kidney Disease

United States
University of Rochester

Terminated

Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria

Proteinuria | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 4

United States
Rigshospitalet, Denmark
Steno Diabetes Center Copenhagen; Herlev and Gentofte Hospital; The Novo Nordisk...

Terminated

NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation

Chronic Kidney Diseases | PreDiabetes | Non-Alcoholic Fatty Liver Disease | Kidney Transplant

Denmark
Cara Therapeutics, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Uremic Pruritus

United States
Cara Therapeutics, Inc.

Completed

CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-2)

Uremic Pruritus

United States, Canada, Czechia, Australia, Germany, Hungary, Korea, Republic of, New Zealand, Poland, Taiwan, United Kingdom
Sanofi

Completed

A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant (START-DCD)

End-stage Renal Disease

China
University of Zurich

Completed

Preserve-Transplant Study

Renal Insufficiency | Kidney Transplantation | Acidosis

Switzerland
AstraZeneca
Parexel

Completed

A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease

Chronic Kidney Disease

United States
Oxford Brookes University
Oxford University Hospitals NHS Trust

Completed

Physical Activity in Haemodialysis Patients: a Feasibility Study (PA-CKD)

End Stage Renal Failure on Dialysis

United Kingdom
University of Florida
National Kidney Foundation

Completed

Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study

Chronic Kidney Diseases | Overweight and Obesity

United States
McMaster University
St. Joseph's Healthcare Hamilton

Withdrawn

Cohort Study Comparing Short Daily Hemodialysis (HD) With Conventional HD

Cardiovascular Diseases | End-stage Renal Disease | Thrombocytopathy

Canada
University Hospital, Montpellier

Completed

Study Evaluating the Pronostic Value of Vascular Refilling Rate on Mortality in Chronic Kidney Disease Patients on Dialysis (REMVAMIR)

Chronic Kidney Diseases

France
Clinical Research Center for End Stage Renal Disease...
Kyungpook National University Hospital; Medical Research Collaborating Center... and other collaborators

Active, not recruiting

Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD)

End-Stage Renal Disease

Korea, Republic of
Mid and South Essex NHS Foundation Trust
University of East Anglia; National Institute for Health Research, United Kingdom and other collaborators

Completed

Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study (ASGARD)

Chronic Kidney Diseases | Gout

United Kingdom
University Medical Center Groningen
Dutch Kidney Foundation; Amphia Hospital; Healthy.io Ltd.; E-Zorg B.V. / KPN Health and other collaborators

Enrolling by invitation

Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches (THOMAS)

Albuminuria

Netherlands
University Medical Center Groningen
Radboud University Medical Center; Erasmus Medical Center; Academisch Medisch...

Completed

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study (RECOVAC-IR)

Covid19 | Chronic Kidney Diseases

Netherlands
AstraZeneca

Completed

A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

Chronic Kidney Diseases | Type 2 Diabetes Mellitus

Spain, United Kingdom, New Zealand, Australia, Canada, Poland, Germany, Japan
Medifil AE
National and Kapodistrian University of Athens; Democritus University of Thrace

Completed

Arteriovenous Fistula Maturation Evaluation Study. FAME Study

Hemodialysis Access Failure | End-stage Renal Disease | Native Arteriovenous Fistula | Vascular Access Maturation

Greece
Prim. Priv. Doz. Dr. Daniel Cejka
Amgen

Completed

A Study to Investigate the Influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients

End Stage Renal Disease

Austria
Bayer

Completed

End-stage Renal Disease (ESRD) Pilot Study

Renal Dialysis

Spain, Belgium, United States, Portugal
Catholic University of Pelotas
Federal University of Pelotas

Enrolling by invitation

Clinical Outcomes of Hemodialysis in Brazil (COHEBRA): a Prospective Cohort Study (COHEBRA)

Chronic Kidney Diseases | Hemodialysis Complication

Brazil
Cipla USA Inc.

Completed

Plazomicin Study in ESRD Patients Receiving IHD

End Stage Renal Disease

United States

Search clinical trials for: Long-term study in Chronic Kidney Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations